Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
T2DM patients with markers of MASLD-related liver fibrosis exhibit lower EF and present indicators of diastolic dysfunction and cardiac hypertrophy. Additionally, LVMi and LAD correlated negatively with serum SHBP concentrations.
Authors
- Theodora Benedek (ORCID: https://orcid.org/0000-0001-8326-1537)
- Andrada Larisa Roiban (ORCID: https://orcid.org/0000-0002-3167-6922)
- Nóra Raț (ORCID: https://orcid.org/0000-0001-6975-5987)
- Danusia Onișor (ORCID: https://orcid.org/0000-0002-5710-9109)
- Simona Cernea (ORCID: https://orcid.org/0000-0002-9494-6571)
Institutions
- Clinical Emergency Hospital Bucharest (RO)
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
- Faculty of Media (SI)
- Spitalul Clinic Judetean de Urgenta Târgu Mureş (RO)
- Spitalul Clinic Judetean Mures (RO)
Publication Details
- Journal
- World Journal of Cardiology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.4330/wjc.v16.i10.580
- Citations
- 10
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.87